American Society Of Retina Specialists Asrs public
[search 0]
More
Download the App!
show episodes
 
Artwork

1
ASRS's History of Retina

American Society of Retina Specialists

Unsubscribe
Unsubscribe
Monthly
 
Welcome to the History of Retina, a continuously unfolding story of the specialty’s dynamic evolution. Trace the journey by exploring milestones in technology, instrumentation and techniques and hearing first-hand accounts from retina pioneers whose innovative spirit and pivotal contributions laid the framework for the advanced sight-saving retinal care of today and the enormously promising treatments of tomorrow.For more information visit https://retinahistory.asrs.org/.
  continue reading
 
Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient car ...
  continue reading
 
Loading …
show series
 
On this episode of ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum, Dr. Timothy Murray welcomes David S. Boyer, MD, of Retina Vitreous Associates Medical Group (LA Retina) Los Angeles, CA, to discuss real-world outcomes for use of the 0.19 mg fluocinolone implant in treating diabetic macular edema in 148 eyes, documenting stable VA, …
  continue reading
 
On this episode of ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum, Dr. Timothy Murray welcomes Michael J. Shapiro, MD, of Retina Consultants in Chicago, IL, who discusses the aggressive onset of familial exudative vitreoretinopathy (FEVR)–like vascular disease in a 3-year-old patient with mutations in LRP5 and TSPAN12 and a 16-year …
  continue reading
 
Join us for an extraordinary Milestones in Retina expert panel discussion detailing the discovery and evolution of a treatment that truly revolutionized the field of retina and the lives of patients around the world – virtually overnight. That therapy is, of course, anti-VEGF. It goes without saying that there is an army of researchers, clinicians,…
  continue reading
 
The History of Retina is pleased to share this Leaders & Legends interview featuring the extraordinary life and career of Mark Blumenkranz, MD. Dr. Blumenkranz is the HU Smead Professor Emeritus and co-director of the Ophthalmic Innovation Program at the Byers Eye Institute at Stanford University School of Medicine. In addition, he serves as manage…
  continue reading
 
Unlike most kids, Eugene de Juan, Jr., preferred his toys broken. Fascinated by his ophthalmologist father’s many gadgets and his grandfather’s workshop, Gene discovered his passion for fixing things at an early age. He went on to complete his ophthalmology and vitreoretinal training at world-class institutions including the Johns Hopkins Universit…
  continue reading
 
Emily Y. Chew, MD, is director of the Division of Epidemiology and Clinical Applications and deputy clinical director of the National Eye Institute (NEI). She is also a senior investigator and Chief of the NEI’s Clinical Trials Branch. In this Leaders & Legends interview Dr. Chew shares fascinating experiences and perspectives from her extraordinar…
  continue reading
 
On this episode of the JVRD Author's Forum, Dr. Timothy Murray joins Philip J. Ferrone, MD, FASRS, to discuss a JVRD case report from the March/April 2024 issue updating our understanding of treatments and outcomes in 36 eyes of 18 patients with incontinentia pigmenti. For more information visit www.ASRS.org/JVRDForum. Welcome to ASRS’s Journal of …
  continue reading
 
On this episode of the JVRD Author's Forum, Dr. Timothy Murray joins John T. Thompson, MD, Associate Editor-in-Chief, to discuss a JVRD article from the March/April 2024 issue on the updated application of the 2020 spectral-domain optical coherence tomography (SD-OCT) consensus to the preoperative classification of macular hole and other macular pa…
  continue reading
 
Leaders & Legends is pleased to share an interview with a true dynamic duo in retina: Drs. Susan and Neil Bressler. Susan and Neil’s personal and professional partnership started in their early days at John Hopkins medical school and, with thoughtful intention, they set out to build their life and careers together. They both pursued ophthalmology r…
  continue reading
 
Dr. Yale Fisher has had an undeniable impact on the field of retina. He led the way in the development of new techniques and instruments in the field, particularly in ultrasonography and vitreoretinal surgery. His pioneering work in ocular endoscopy has expanded the boundaries of what is possible in the field and he has shared his expertise extensi…
  continue reading
 
Dr. Stuart L. Fine is world-renowned for his leadership in ophthalmology education, research, and patient care. A pioneering investigator, Dr. Fine helped shape the field of retina through his leadership of numerous National Eye Institute (NEI)-supported, multi-centered clinical trials to evaluate new and existing treatments for retinal disease. Am…
  continue reading
 
In this episode, Dr. Timothy Murray joins Dr. Jennifer Aye to talk about a case of recurrent aggressive ciliochoroidal melanoma requiring enucleation after brachytherapy elsewhere for recurrence at the biopsy site. The tumor showed progression from gene expression profiling (GEP) class 1A, PRAME negative to GEP Class 1b. For more information visit …
  continue reading
 
In this episode, Dr. Timothy Murray joins Dr. Lejla Vajzovic to discuss the impact of e-cigarette use on macular perfusion employing optical coherence tomography angiography (OCTA) in a study of 25 patients. Learn if there are differences in retinal microvasculature measurements in patients using e-cigarettes compared to nonsmoker control groups. F…
  continue reading
 
In this episode, Dr. Timothy Murray welcomes Steven Yeh, MD, University of Nebraska Medical Center, Truhlsen Eye Institute to discuss 3 cases of retinopathy secondary to ritonavir use in the treatment of HIV. The review identified 3 patients with a history of HIV treated with antiretroviral therapy including ritonavir who had been evaluated for bil…
  continue reading
 
On this episode, Dr. Murray welcomes Andre Witkin, MD, Associate Professor, Tufts University School of Medicine, Boston, MA, to discuss the article, Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee. On February 17, 2023, pegcetacoplan 15mg (Syfovre – Apellis Pharmaceutica…
  continue reading
 
In this episode, the History of Retina welcomes retina leader and legend, Morton F. Goldberg, MD, who shares stories from his extraordinary career. Listen in as he recalls co-hosting the 1968 Arlie House Symposium on the Treatment of Diabetic Retinopathy with colleague Stuart Fine, MD. This groundbreaking international meeting of the world’s expert…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Dr. Baruch Kuppermann, Gavin Herbert Eye Institute, University of California, Irvine, California, to explore evidence from other specialties regarding cross-switching between biosimilars, and learn if there are any foreseen patient safety concerns for retina specialists. For more information visit www.AS…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Colin McCannel, MD, from Stein Eye and Doheny Institutes, University of California, Los Angeles, California, to discuss a case report on the long-term outcomes of 2 cases of primary autologous stem cell transplantation (ASCT) for the treatment of primary central nervous system lymphoma–ophthalmic variant…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Aleksandra Rachitskaya, MD, FASRS, of Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio to explore the effect of syringe type on developing sustained intraocular pressure (IOP) increases. Learn how the type of syringe may or may not affect outcomes. For more information visit www.ASRS.org/JVRDForum. …
  continue reading
 
On this episode, Dr. Timothy Murray welcomes R. Rishi Gupta, MD, FRCSC, FASRS, associate professor at Dalhousie University, Halifax, Nova Scotia, to discuss a case report on how a case of postoperative persistent loculated subretinal fluid (SRF) developed after pars plana vitrectomy (PPV) for vitreomacular traction (VMT) syndrome. Explore the manag…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Xuejing Chen, MD, assistant professor at Boston University School of Medicine, to discuss a study on how the pandemic affected people from variable demographics. Explore the data and learn if the pandemic affected access to intravitreal injection treatments. For more information visit www.ASRS.org/JVRDFo…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Sean D. Adrean, MD, from Retina Consultants of Orange County, to discuss a case of retinopathy secondary to intense coughing and vomiting as symptoms of COVID-19. Learn about the diagnosis and eventual surgical management. For more information visit www.ASRS.org/JVRDForum. Welcome to ASRS’s Journal of Vi…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Daniel M. Miller, MD, PhD, FASRS, of Cincinnati Eye Institute, to discuss a surgical technique that affects patients with port delivery system implants who experience a conjunctival erosion. For more information visit www.ASRS.org/JVRDForum. Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Auth…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Charles C. Wykoff, MD, PhD, FASRS, Retina Consultants of Texas, to discuss the study on the comparison of rates of endophthalmitis (1) following intravitreal injection of antivascular endothelial growth factor therapies with glass-vial preparation (GVP) vs prefilled syringes (PFS) and (2) before and afte…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Sharon Fekrat, MD, FACS, FASRS, Duke University, to discuss a case involving a 29-year-old, obese, hypertensive man who presented with a 10-day history of progressive vision loss in the left eye with no history of trauma. The visual acuity was 20/25 OD and hand motions OS. Learn the importance of one con…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Dr. Caroline Awh, an ophthalmology resident, to discuss a recent JVRD case report from the July/August issue on a rare cause of fungal endophthalmitis. Learn how this case poses significant diagnostic and management challenges. For more information visit www.ASRS.org/JVRDForum. Welcome to ASRS’s Journal …
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Dr. Ella Leung, from Georgia Retina, to discuss Medicare reimbursements for the physician work component of vitreoretinal surgeries as a significant opportunity cost for the physician relative to office-based patient care of equivalent time. Explore how the current analysis compares Medicare physician re…
  continue reading
 
On this episode, Dr. Timothy Murray welcomes Dr. Audina Berrocal from Bascom Palmer Eye Institute to discuss a recent JVRD case report from the July/August issue on preterm newborns with ROP and vitreous opacification thought to be caused by hyperbilirubinemia. Because of vitreous opacification, these patients could not be properly examined for ROP…
  continue reading
 
On this episode of the JVRD Author's Forum, Dr. Timothy Murray welcomes Dr. Paul Hahn of NJ Retina to discuss a JVRD article from the May/June 2023 issue on DME treatments between 2015 and 2020 by US retina specialists. Learn whether practice patterns align with conclusions from major randomized DME clinical trials. Real world outcomes and clinical…
  continue reading
 
On this episode of the JVRD Author's Forum, Dr. Timothy Murray welcomes Dr. Mark Seamone from the University of Alberta to discuss a JVRD article from the May/June 2023 issue on surgery success rates of vitrectomy with a macular off retinal detachment. Learn whether peeling the ILM is the right approach for patients in certain subsets of retinal de…
  continue reading
 
Since its founding in 1982, the American Society of Retina Specialists (ASRS) has grown exponentially in size and influence, making it a powerful national advocate and primary source of clinical and scientific information and education for its members. It does, in fact, represent all things retina. Listen in as ASRS founders, Drs. Jerald Bovino, Ro…
  continue reading
 
Daniel Martin, MD, FASRS, has focused much of his extraordinary career on the design and execution of clinical trials to evaluate new drugs and therapeutic strategies for retinal disease. He has been – and is still -- at the helm of some of the most influential retina research of our time. His contributions have not only guided treatment practices,…
  continue reading
 
Few people have thought as deeply about retina’s most perplexing questions as Richard Spaide, MD. He is a brilliant innovator and ‘retinal philosopher’ whose research and novel theories on the pathophysiology of retinal disorders have spawned nearly 400 peer-reviewed publications, including many of the most-cited and influential papers in the field…
  continue reading
 
Beyond his operating room wizardry and passion for patient care, Donald J. D’Amico, MD, FASRS, is recognized for his gift of oratory which has made him a world-renowned lecturer, moderator and educator. In this compelling interview, Dr. D’Amico recounts fascinating stories of his early days in practice, including his experience operating with the F…
  continue reading
 
A recognized pioneer in retinal imaging, Lawrence A. Yannuzzi, MD, is a revered practitioner and educator who has earned an international reputation for his keen observational skills, inquisitive mind and the ability to publish findings at lightning speed. In this Leaders & Legends interview, Dr. Yannuzzi shares interesting insights into his career…
  continue reading
 
In this inspiring interview you’ll hear from the remarkable Carol L. Shields, MD, FASRS, a true pioneer in every sense of the word. Listen in as she recalls her childhood making house calls with her physician father, her years captaining Notre Dame’s first championship varsity women's basketball team, her induction into the Academic Hall of Fame, t…
  continue reading
 
Retina pioneer and innovator Gary W. Abrams, MD, FASRS, discusses his inspiring professional journey spanning numerous groundbreaking advancements in the field, from the advent of the air pump and endolaser, to gas, silicone oil, perfluorocarbon liquid, vitrectomy and wide-angle viewing. Listen as he recalls his memorable job interview with Robert …
  continue reading
 
Since vision issues and blindness were first diagnosed and documented, scientists have sought a cure. In this video, ASRS Foundation President Timothy G. Murray, MD, MBA, FASRS, talks with Mark S. Humayun, MD, PhD, an internationally recognized pioneer in vision restoration who assembled a multidisciplinary team of experts to develop the first FDA-…
  continue reading
 
History of Retina Co-director Kirk H. Packo, MD, FASRS, hosts an all-star panel of retina giants, who recount the coming of age of vitrectomy surgery. Listen in as Drs. Thomas Aaberg, Sr., Gary Abrams, Steve Charles, Gene de Juan, and Wayne Fung share their compelling first-hand accounts of vitrectomy from the early days of open sky and the Vail Vi…
  continue reading
 
Audina Berrocal, MD, FASRS, is one of the world’s leading experts in the surgical management of retinopathy of prematurity and pediatric vitreoretinal disorders. She is also the youngest daughter of Jose Berrocal, MD, who was the first retina fellow at the Bascom Palmer Eye Institute in 1963 and went on to be the first retina surgeon in Puerto Rico…
  continue reading
 
An extraordinary look back with George Williams, MD, FASRS, who discusses his experience during the Aaberg-Abrams era at the Medical College of Wisconsin, his groundbreaking exploration of pharmacological ways to manipulate the vitreous and the birth of retinal pharmacology. A staunch crusader on behalf of retina, Dr. Williams is a recognized healt…
  continue reading
 
A fascinating conversation with Dr. Harry Flynn who recounts his stellar career. A visionary surgeon who has introduced numerous innovations and new technologies to the operating room, he discusses the evolution of small-gauge surgery, his collaborations with the legendary Jean-Marie Parel, Ing. ETS-G, PhD, his love of research, working with reside…
  continue reading
 
In 1971, Dr. Robert Machemer, Anton Banko and Jean-Marie Parel designed the vitreous infusion cutter (VISC), one of the first commercially available instruments to remove vitreous during a vitrectomy. Shortly thereafter, Mark Mandelcorn, MD, FRCSC, arrived at Bascom Palmer from Toronto and became Dr. Machemer’s first fellow, working directly alongs…
  continue reading
 
A truly fascinating discussion with Kirk H. Packo, MD, FACS, FASRS, an internationally renowned vitreoretinal surgeon whose unique creativity, intellect and story-telling abilities have made him a legendary teacher of retina. Listen as Dr. Packo reflects on his mentors, and his experience coming of age in retina during the ‘heyday’ of instrument de…
  continue reading
 
In this compelling panel discussion, host Timothy G. Murray, MD, MBA, FASRS, explores the history of scleral buckling through the first-hand accounts of renowned vitreoretinal surgeons Allan (Buzz) Kreiger, MD; Charles (Pat) Wilkinson, MD, MA; Gary W. Abrams, MD; and Michael Lambert, MD. The experts share their professional experiences with scleral…
  continue reading
 
It would be hard to imagine retina surgery today without the contributions of Steve Charles, MD, FACS, FICS, FASRS . Over the course of his amazing career, he has amassed over 100 patents, introducing among other things, scissor segmentation, the linear vacuum, disposable cutters, retinectomy, the Ocutome 8000, and ‘medium term PFO.’ Listen as he d…
  continue reading
 
Julia Haller, MD, FASRS is a world-renowned retina surgeon and scientist who has innovated significant translational advances against blindness. She discusses her remarkable journey in academic and organized medicine, including being among the first to administer gene therapy and to inject anti-VEGF in a human eye. A trailblazer for women in retina…
  continue reading
 
In this interview with one of retina’s true giants, Mike Trese, MD, details his remarkable 45-year career spearheading revolutionary developments in both pediatric and adult retina. He shares the challenges of navigating blinding diseases with the youngest and most vulnerable patients and the amazing advances that have increased the success rate fo…
  continue reading
 
An extraordinary conversation with Thomas Aaberg Sr., MD, FASRS, and son Thomas Aaberg Jr., MD, who share a rare look inside the early years in retina. Tom Aaberg Sr., discusses his remarkable career, early innovations that moved the needle, and his friendship and collaborations with Robert Machemer, MD. Tom Aaberg Jr., MD, adds his recollections f…
  continue reading
 
Invention of the vitreous infusion suction cutter (VISC) for vitrectomy surgery revolutionized the field of retina in the 1970s. Now, more than 50 years later, the VISC remains central to every retinal surgeons armamentarium and no one is more surprised than the man behind its development -- Jean-Marie Parel, Ing.ETS-G, PhD, FARVO. In this extraord…
  continue reading
 
Loading …

Quick Reference Guide